5Trouillas P,Takayanagi T,Hallett M,et al.International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome.The Ataxia Neuropharmacology Committee of the World Federation of Neurology[J].J Neurol Sci,1997,145(2):205-211.
6Buchsbaum RJ.Rho activation at a glance[J].J Cell Sci,2007,120(Pt7):1149-1152.
7Watanabe Y,Faraci FM,Heistad DD.Activation of Rho-associated kinase during augmented contraction of the basilar artery to serotonin after subarachnoid hemorrhage[J].Am J Physiol Heart Circ Physiol,2005,288(6):H2653-H2658.
8Rikitake Y,Kim HH,Huang Z,et al.Inhibition of Rho kinase (ROCK)leads to increased cerebraI blood flow and stroke protection[J].Stroke,2005,36(10):2251-2257.
9Zhao J,Zhou D,Guo J,et al.Effect of fasudil hydrochloride,a protein kinase inhibitor,on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage[J].Neurol Med Chir(Tokyo),2006,46(9):421-428.
10Yamashita K,Kotani Y,Nakajima Y,et al.Fasudil,a Rho kinase (ROCK) inhibitor,protect against ischemic neuronal damage in vitro and in vivo by acting directly on neurons[J].Brain Res,2007,1154:215-224.
